Fig. 7: Study and sample enrollment diagram.
From: Navigating complexities of polymorphic microbiomes in endometrial cancer
N = 200 women enrolled in the Endometrial Cancer study with histologically confirmed diagnoses of benign gynecological conditions (n = 108), endometrial hyperplasia (n = 18), grade 1/2 endometrial endometrioid carcinoma (n = 56), other endometrioid carcinomas (n = 13), and other gynecologic cancers. n = 8 women were diagnosed with other gynecologic cancers, so were excluded from the analysis, resulting in our study population of n = 192 women. The number of samples excluded after microbiome preprocessing were n = 13 for vaginal and n = 13 for rectal.
